XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 2,565,982 $ 3,081,577 $ 4,785,509 $ 4,840,597
General and administrative 1,655,152 2,032,339 2,606,804 3,562,301
Total operating expenses 4,221,134 5,113,916 7,392,313 8,402,898
Operating loss (4,221,134) (5,113,916) (7,392,313) (8,402,898)
Other income (expense)        
Change in fair value of warrant liabilities (161,714)   (9,396,636)  
Grant income 153,685   501,529 27,057
Currency exchange gain (loss) (47,487) (72,594) (74,675) (127,943)
Interest income 148 178 294 346
Interest expense   (4,482) (114) (14,188)
Total other income (expense) (55,368) (76,898) (8,969,602) (114,728)
Net loss attributable to common stockholders [1] $ (4,276,502) $ (5,190,814) $ (16,361,915) $ (8,517,626)
Weighted-average common shares outstanding, Basic [1] 833,654 7,631 504,252 6,598
Weighted-average common shares outstanding, Diluted [1] 833,654 7,631 504,252 6,598
Net loss per share, Basic [1] $ (5.13) $ (680.23) $ (32.45) $ (1,290.94)
Net loss per share, Diluted [1] $ (5.13) $ (680.23) $ (32.45) $ (1,290.94)
[1] On May 15, 2025, the Company effected a reverse split of the Company's common stock, either issued and outstanding or held by the Company as treasury stock. The May 2025 Reverse Split was at a ratio of one share for every 28 shares previously held with no change in the par value per share. The May 2025 Reverse Split did not change the number of authorized shares of common stock. All common stock share and per share data, and exercise price data for applicable common stock equivalents, included in these financial statements have been retroactively adjusted to reflect the Reverse Split.